Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

BACKGROUND: Dry eye disease (DED) affects more than 14% of the elderly population causing decrease of quality of life, high costs and vision impairment. Current treatments for DED aim at lubricating and controlling inflammation of the ocular surface. Development of novel therapies targeting differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacchetti, Marta, Lambiase, Alessandro, Schmidl, Doreen, Schmetterer, Leopold, Ferrari, Mauro, Mantelli, Flavio, Allegretti, Marcello, Garhoefer, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922013/
https://www.ncbi.nlm.nih.gov/pubmed/30944103
http://dx.doi.org/10.1136/bjophthalmol-2018-312470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922013/
https://www.ncbi.nlm.nih.gov/pubmed/30944103
http://dx.doi.org/10.1136/bjophthalmol-2018-312470

Ejemplares similares